Jericho Assisted Living
Tuesday, June 14, 2016
Biosimilar Insulin Glargine Matches Up With Lantus in Phase III
(MedPage Today) -- Merck's copycat has similar HbA1c effect in trial
via
Biosimilar Insulin Glargine Matches Up With Lantus in Phase III
by
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment